Martina Kovac
Pharmaceutical Product Development (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Bacterial Infections and Vaccines, Pneumonia and Respiratory Infections, Influenza Virus Research Studies, Acne and Rosacea Treatments and Effects
Most-Cited Works
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial(2013)162 cited
- → Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials(2019)62 cited
- → Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial(2017)53 cited
- → Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials(2018)45 cited
- → Lasting immune memory against hepatitis B following challenge 10–11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11–12 months of age(2014)33 cited
- → Influenza symptoms and their impact on elderly adults: randomised trial of AS03‐adjuvanted or non‐adjuvanted inactivated trivalent seasonal influenza vaccines(2014)29 cited
- → Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study(2018)22 cited
- Secular rhythms and Halberg's paraseasonality in the time occurrence of cerebral stroke.(2005)
- → Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials(2022)14 cited